These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 10347130)
21. Cytogenetic and molecular genetic alterations in hepatocellular carcinoma. Lau SH; Guan XY Acta Pharmacol Sin; 2005 Jun; 26(6):659-65. PubMed ID: 15916730 [TBL] [Abstract][Full Text] [Related]
22. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Iizuka N; Oka M; Yamada-Okabe H; Mori N; Tamesa T; Okada T; Takemoto N; Tangoku A; Hamada K; Nakayama H; Miyamoto T; Uchimura S; Hamamoto Y Cancer Res; 2002 Jul; 62(14):3939-44. PubMed ID: 12124323 [TBL] [Abstract][Full Text] [Related]
23. Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis. Wong N; Lai P; Lee SW; Fan S; Pang E; Liew CT; Sheng Z; Lau JW; Johnson PJ Am J Pathol; 1999 Jan; 154(1):37-43. PubMed ID: 9916916 [TBL] [Abstract][Full Text] [Related]
24. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma. Momosaki S; Nakashima Y; Kojiro M; Tabor E J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475 [TBL] [Abstract][Full Text] [Related]
25. Etiologic influence on chromosomal aberrations in European hepatocellular carcinoma identified by CGH. Homayounfar K; Schwarz A; Enders C; Cameron S; Baumhoer D; Ramadori G; Lorf T; Gunawan B; Sander B Pathol Res Pract; 2013 Jun; 209(6):380-7. PubMed ID: 23706943 [TBL] [Abstract][Full Text] [Related]
26. Analysis of DNA copy number aberrations in hepatitis C virus-associated hepatocellular carcinomas by conventional CGH and array CGH. Hashimoto K; Mori N; Tamesa T; Okada T; Kawauchi S; Oga A; Furuya T; Tangoku A; Oka M; Sasaki K Mod Pathol; 2004 Jun; 17(6):617-22. PubMed ID: 15133472 [TBL] [Abstract][Full Text] [Related]
27. Assessment of differentiation and progression of hepatic tumors using array-based comparative genomic hybridization. Steinemann D; Skawran B; Becker T; Tauscher M; Weigmann A; Wingen L; Tauscher S; Hinrichsen T; Hertz S; Flemming P; Flik J; Wiese B; Kreipe H; Lichter P; Schlegelberger B; Wilkens L Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1283-91. PubMed ID: 16979954 [TBL] [Abstract][Full Text] [Related]
28. Cytogenetic alterations in liver cell tumors as detected by comparative genomic hybridization. Terracciano L; Tornillo L Pathologica; 2003 Apr; 95(2):71-82. PubMed ID: 12768875 [TBL] [Abstract][Full Text] [Related]
29. Genomic aberrations in carcinomas of the uterine corpus. Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002 [TBL] [Abstract][Full Text] [Related]
30. High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma. Chan KL; Guan XY; Ng IO Hum Pathol; 2004 Nov; 35(11):1324-31. PubMed ID: 15668888 [TBL] [Abstract][Full Text] [Related]
31. Losses of chromosome arms 4q, 8p, 13q and gain of 8q are correlated with increasing chromosomal instability in hepatocellular carcinoma. Hertz S; Rothämel T; Skawran B; Giere C; Steinemann D; Flemming P; Becker T; Flik J; Wiese B; Soudah B; Kreipe H; Schlegelberger B; Wilkens L Pathobiology; 2008; 75(5):312-22. PubMed ID: 18931534 [TBL] [Abstract][Full Text] [Related]
32. Determination of the molecular relationship between multiple tumour nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis. Ng IO; Guan XY; Poon RT; Fan ST; Lee JM J Pathol; 2003 Mar; 199(3):345-53. PubMed ID: 12579536 [TBL] [Abstract][Full Text] [Related]
33. Distinct chromosomal bias of gene expression signatures in the progression of hepatocellular carcinoma. Midorikawa Y; Tsutsumi S; Nishimura K; Kamimura N; Kano M; Sakamoto H; Makuuchi M; Aburatani H Cancer Res; 2004 Oct; 64(20):7263-70. PubMed ID: 15492245 [TBL] [Abstract][Full Text] [Related]
34. PTK2 and EIF3S3 genes may be amplification targets at 8q23-q24 and are associated with large hepatocellular carcinomas. Okamoto H; Yasui K; Zhao C; Arii S; Inazawa J Hepatology; 2003 Nov; 38(5):1242-9. PubMed ID: 14578863 [TBL] [Abstract][Full Text] [Related]
35. Genetic changes and histopathological grades in human hepatocellular carcinomas. Konishi M; Kikuchi-Yanoshita R; Tanaka K; Sato C; Tsuruta K; Maeda Y; Koike M; Tanaka S; Nakamura Y; Hattori N Jpn J Cancer Res; 1993 Aug; 84(8):893-9. PubMed ID: 8407553 [TBL] [Abstract][Full Text] [Related]
36. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas. Shao J; Li Y; Li H; Wu Q; Hou J; Liew C Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078 [TBL] [Abstract][Full Text] [Related]
37. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features. Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663 [TBL] [Abstract][Full Text] [Related]
38. Molecular targets for therapy of hepatitis B virus-induced hepatocellular carcinoma. Tharayil VS; Roberts LR Minerva Gastroenterol Dietol; 2006 Dec; 52(4):387-406. PubMed ID: 17108869 [TBL] [Abstract][Full Text] [Related]
39. Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects. Buendia MA Med Pediatr Oncol; 2002 Nov; 39(5):530-5. PubMed ID: 12228912 [TBL] [Abstract][Full Text] [Related]